TX-TQ-DELTA
30.5.2019 00:13:05 CEST | Business Wire | Press release
TQ Delta LLC, a technology development and licensing firm, secured another favorable judgment last week when a Delaware federal jury found that 2Wire Inc. infringed three of TQ Delta’s patents related to Digital Subscriber Line (“DSL”) technology. 2Wire is a subsidiary of ARRIS Solutions, which was recently acquired by CommScope Inc.
TQ Delta’s patents cover important memory sharing capabilities for DSL modems and central office equipment, among other inventions. TQ Delta notes that these inventions are widely employed not just in the United States, but around the world.
This ruling represents another victory for TQ Delta’s ongoing licensing business. Earlier this year, the High Court of Justice of England and Wales also found in favor of TQ Delta on another patent from its deep portfolio of DSL inventions. The UK Proceeding against ZyXEL Communications UK Ltd and its Danish parent company, ZyXEL Communications A/S (both subsidiaries of Unizyx Holding Corporation) found TQ Delta’s European Patent (UK) 1 453 268 valid and infringed, as well as essential to the standards for ADSL2 and VDSL2. The Court granted an immediate injunction and award of costs against the ZyXEL defendants. ZyXEL defendants have appealed some elements of the judgment and that appeal is pending. TQ Delta’s worldwide portfolio spans a broad range of standard essential patents (“SEPs”) and non-SEPs that are central to key broadband network technologies. In addition to validation by courts in the US and UK, TQ Delta has successfully licensed its technology to key market participants.
The most recent verdict was announced on May 23 following a nearly four-day trial in the United States District Court for the District of Delaware. After deliberation, the eight-member jury returned a favorable verdict on all eleven counts, finding that 2Wire infringed U.S. Patent nos. 7,836,381, 7,844,882 and 8,276,048, that those patents were not obvious over prior art, and that two certificates of correction were not invalid.
“We are pleased with the jury’s decision affirming the strength and importance of our portfolio of inventions, which are the culmination of years of investment in standards development and communications technologies,” said Abha Divine, Managing Director of TQ Delta.
TQ Delta has supported continued development of DSL markets by maintaining a longstanding business strategy designed to ensure advancements in the technology. “The TQ Delta portfolio and continued investment in the field contributes to the past, present, and future of high-speed DSL connections around the world. We have already licensed several companies to practice the important inventions under our DSL portfolio and will continue to seek to license others through business negotiations,” said Divine.
TQ Delta was represented by McAndrews, Held, and Malloy, Ltd., a firm specializing in intellectual property prosecution, counselling, and dispute resolution.
Lead trial attorney, Peter McAndrews, explained that “The Defendant’s strategy was to trivialize the important inventions at issue. We are pleased that the jury vindicated the inventors’ hard work and our client’s commitment to innovation.”
TQ Delta maintains a sizable patent portfolio for digital communication technology, including DSL.
About TQ Delta
TQ Delta is a technology development and licensing company aimed at providing needed solutions for the communications industry and beyond. The company’s technical investments span nearly two decades of contributions and innovation in the field of communications. TQ Delta’s technologies are used in leading products and services worldwide spanning broadband communications and media distribution. For more information, visit http://www.tqdelta.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190529005990/en/
Contact:
Scott Krady Magnitude, Inc. scott@magnitudegrowth.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Debiopharm’s Pre-Clinical Proof-Of-Concept Research Unveils the Potential of Novel MultiLINK Linker Technology to Overcome Tumor Resistance14.10.2026 14:00:00 CEST | Press release
Despite the remarkable progress made by ADCs, many cancer patients continue to face disease progression due to treatment resistance, tumor heterogeneity, and dose-limiting toxicities At World ADC 2026 San Diego, Debiopharm presented their latest ADC innovation to overcome these challenges with novel linker-payload technology, including modular dual payload linker MLINK DUO and modular cathepsin B-cleavable linker MLINK Select Research results with various MultiLINKTM Linker Technologies showcased broadening of vedotin-based ADC therapeutic index for MLINK Select ADCs, synergistic antitumor activity with MLINK Duo, and homogeneous DAR8 conjugation with MLINK HiSol Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, today announced their latest research on antibody drug conjugate (ADC) research released at World ADC San Diego 2026. Results highlighted the pre-cli
Responsible AI for Children: IEEE Delivers a Trusted Safety Formula to Help Protect Kids Online14.10.2026 14:00:00 CEST | Press release
With children’s AI exposure surging, IEEE Standards Association certification helps ensure AI products for kids are ethically designed, independently tested and continually accountable for safety and well-beingFirst product certification issued to educational platform from Greek National Centre for Scientific Research The IEEE Standards Association, the global, consensus-building standards development organization of IEEE – the world’s largest technical professional organization and public charity dedicated to advancing technology for the benefit of humanity – today advanced its Responsible AI for Children (RAIC) Certification Program with the first product certified for children’s online safety. As children increasingly engage with digital and AI-enabled technologies, parents, educators, developers, and regulators want tools they can trust. IEEE’s Responsible AI for Children (RAIC) certification directly addresses these needs by translating global technical standards into a practical
Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 202614.10.2026 14:00:00 CEST | Press release
− TAK-881 met its primary endpoint, demonstrating pharmacokinetic comparability to HYQVIA® in patients 16 years and older − TAK-881 may shorten infusion times and offer the opportunity for fewer required infusion sites compared to HYQVIA with 50% less volume while maintaining up to once-monthly dosing − Adult infection outcomes and safety and tolerability profiles were comparable to HYQVIA based on descriptive analyses and consistent with established IG therapy standards Takeda (TSE:4502/NYSE:TAK) announced detailed results from the pivotal Phase 2/3 IgGNITE clinical trial (TAK-881-3001) evaluating investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) and Recombinant Human Hyaluronidase], which, if approved, has the potential to become the first facilitated SCIG 20% therapy for patients with Primary Immunodeficiency Disease (PID) administered up to once-monthly (every 3 to 4 weeks). Data in participants aged 16 years and older are featured in two late-b
Datavault AI Appoints Shareholder and Investment Executive Jeffrey Tirman to the Boardof Directors14.10.2026 13:55:00 CEST | Press release
Tirman, through his family office Abri Capital Ltd., holds 26 million DVLT shares and brings over 35 years of international investment management and corporate restructuring experience to the Company Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and real-world asset (“RWA”) tokenization, today announced the appointment of Jeffrey Tirman to its Board of Directors, effective as of October 12, 2026. Mr. Tirman was designated by NYIAX, Inc. (“NYIAX”) in connection with Datavault AI's recently completed acquisition of NYIAX, and he previously served on NYIAX's board of directors. As a Datavault AI Shareholder, Mr. Tirman brings both an ownership perspective and extensive management experience to the Board. Mr. Tirman has more than 35 years of international investment management experience, focused on corporate transformation, capital strategy and value creation. He has led c
EZO Reaches Financial Close on €150 Million Senior Debt Facility14.10.2026 13:21:00 CEST | Press release
Investment-grade, non-recourse financing will support the delivery of more than 3,000 charge points primarily across the whole of the UK along with additional development in Ireland. EZO has reached financial close on a €150 million investment-grade, non-recourse, senior debt facility. The funding will finance the design, installation, operation and maintenance of over 3,000 charge points, representing over 100,000 kWs of capacity, across the UK and Ireland under mostly long-term public sector “PPP-like” concessions with an attractive risk allocation between the public and private sector that will significantly advance EV infrastructure delivery, on time and to budget. These charge points are estimated to generate well in excess of £1 billion in electricity sales over the next 20 years, a portion of which will be shared with the public sector while, at the end of the concession, the chargers will revert back to the public sector. Headquartered in Ireland, EZO has expanded rapidly into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom